Search All UT System Experts

Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non–Small-Cell Lung Cancer (RTOG 3505)

David E. Gerber, James J. Urbanic, Corey Langer, Chen Hu, I. Fen Chang, Bo Lu, Benjamin Movsas, Robert Jeraj, Walter J. Curran, Jeffrey D. Bradley

Research output: Contribution to journal › Article › peer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non–Small-Cell Lung Cancer (RTOG 3505)'. Together they form a unique fingerprint.

Medicine & Life Sciences